OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹43 Cr | ₹8.49 Cr | ₹17 Cr | ₹11 Cr | ₹6.33 Cr |
What is the latest Cash Flow from Financing Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹8.49 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹6.33 Cr |
How is Cash Flow from Financing Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | 401.38 | |
| Mar2025 | ₹8.49 Cr | -50.46 | |
| Mar2024 | ₹17 Cr | 52.64 | |
| Mar2023 | ₹11 Cr | 77.26 | |
| Mar2022 | ₹6.33 Cr | - | |
Compare Cash Flow from Financing Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹223.3 Cr | -5.5% | 18.4% | -29.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -5.5% |
18.4% |
-29.1% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses